United States
Print page content Print
Increase text size Decrease text size
Text Size

PNEUMABORT-K® +1b

Equine Rhinopneumonitis Vaccine Killed Virus

Pneumabort-K+1b is the only equine vaccine labeled to help prevent respiratory disease caused by equine herpesvirus (EHV)-1p and EHV-1b as well as for use in pregnant mares as an aid in the prevention of abortion due to EHV-1 infections.

Expand All
  • Broad protection—the only equine vaccine labeled to help prevent respiratory disease caused by equine herpesvirus (EHV)-1p and EHV-1b, as well as for use in pregnant mares as an aid in the prevention of abortion due to EHV-1 infections.

    Prevalence—the 1b subgroup of EHV-1 continues to be an important group, as are abortions associated with EHV-1 infections.1

    PNEUMABORT-K +1b is uniquely adjuvanted for improved immune responses.

    Recommended for whole-herd management, including geldings, stallions and mares where there is evidence of EHV-1 in the herd population.

  • For pregnant mares, aseptically administer one 2 mL dose intramuscularly during the 5th, 7th and 9th months of pregnancy. Revaccinate annually at the 5th, 7th and 9th months of pregnancy.

    For young horses, aseptically administer one 2 mL dose intramuscularly followed by a second 2 mL dose 3 to 4 weeks later. Revaccinate with a single 2 mL dose 6 months after the second primary dose and annually thereafter. To insure proper placement and retention of the vaccine, inject deep into the heavy muscles of the hindquarter. Mild exercise to promote absorption is recommended for one week after injection

  • 1. Paillot R, Case R, Ross J, Newton R, Nugent J. Equine Herpes Virus :Virus, Immunity and Vaccines, The Open Veterinary Science Journal 2008;2,68-91.


Important Safety Information

For veterinary use only.